Fresenius Kabi Introduces Cancer Copay Scheme For Generics
Some Patients Could Find Their Monthly Costs Entirely Eliminated
German pharma giant Fresenius Kabi has introduced a copay scheme for a number of its generic oncology medicines in the US, which could completely eliminate monthly costs for certain patients.
